Drawing for CARDIOVANT

USPTO serial 79251678

CARDIOVANT

Reviewed by CopyMark Law Group

Reg. 5963955Status 709
Filing date
Status date
Registration date
Jan 21, 2020
Examiner
HISER, CHARLES
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CARDIOVANT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Allison Strickland Ricketts

Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment of cardiovascular diseases, disorders and conditions; biological preparations for medical or therapeutic purposes for the treatment of cardiovascular diseases, disorders and conditionsSECTION 71 - CANCELLED—
042Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biologic therapeutic research services; scientific research in the fields of pharmaceutical and biological therapeutic preparations, clinical trials and examinations carried out after the introduction of medicines on the market; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicines, clinical trials and post-market trialsSECTION 71 - CANCELLED—
044Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biological preparations for the prevention and treatment of diseases, disorders and conditionsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 7, 2026C71TCANCELLED SECTION 71—
Jan 21, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 22, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 30, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 30, 2020FIMPFINAL DISPOSITION PROCESSED—
Apr 21, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 21, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 5, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2019RFNPREFUSAL PROCESSED BY IB—
Apr 18, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 26, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 26, 2019RFRRREFUSAL PROCESSED BY MPU—
Mar 17, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 16, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2019DOCKASSIGNED TO EXAMINER—
Feb 23, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 19, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 15, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance